Research Article
Exploiting the Concept of Multivalency with 68Ga- and 89Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression
Table 3
Corresponding tumour-to-organ ratios of 68Ga- and 89Zr-labelled bioconjugates; data are presented as mean ± SD.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statistical analysis was performed using the Student’s -test with values indicating significant () difference (a) between mono- and dimer, (b) between mono- and trimer, (c) between di- and trimer, (d) between 68Ga-labelled tracers and corresponding 89Zr-labelled counterparts, (e) between 1 h and 2 h, and (f) between 2 h and 4 h of radiolabelled trimer. |